U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H18Cl2N2O6S
Molecular Weight 413.274
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIAMPHENICOL AMINOACETATE

SMILES

CS(=O)(=O)C1=CC=C(C=C1)[C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl

InChI

InChIKey=AMGKHLVPQHMHGQ-ZYHUDNBSSA-N
InChI=1S/C14H18Cl2N2O6S/c1-25(22,23)9-4-2-8(3-5-9)12(20)10(7-24-11(19)6-17)18-14(21)13(15)16/h2-5,10,12-13,20H,6-7,17H2,1H3,(H,18,21)/t10-,12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C14H18Cl2N2O6S
Molecular Weight 413.274
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15224555 and https://www.drugs.com/international/urfamycin.html

Thiamphenicol aminoacetate is an antibiotic. It is the methyl-sulfonyl analogue of chloramphenicol and has a similar spectrum of activity, but is 2.5 to 5 times as potent. It is used in many countries as a veterinary antibiotic, but is available in China, Morocco and Italy for use in humans. Thiamphenicol aminoacetate is reported as an ingredient of Urfamycin in Ecuador, Indonesia, Italy, Taiwan, Thailand, Turkey, Japan. It is indicated for the treatment of GUT, hepatobiliary, respiratory tract, enteric tract infections, typhoid, paratyphoid fever and salmonellosis, brucellosis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Neisseria gonorrhoeae growth
Target ID: Moraxella catarrhalis growth
Target ID: Streptococcus pneumoniae growth
Target ID: Haemophilus influenzae growth
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Urfamycin

Approved Use

GUT, hepatobiliary, resp tract, enteric tract infections, typhoid, paratyphoid fever & salmonellosis, brucellosis.
Curative
Urfamycin

Approved Use

GUT, hepatobiliary, resp tract, enteric tract infections, typhoid, paratyphoid fever & salmonellosis, brucellosis.
Curative
Urfamycin

Approved Use

GUT, hepatobiliary, resp tract, enteric tract infections, typhoid, paratyphoid fever & salmonellosis, brucellosis.
PubMed

PubMed

TitleDatePubMed
[Re-evaluation of single-dose treatment with thiamphenicol and spectinomycin of uncomplicated male gonococcal urethritis].
1987
Comparative in vitro activity of thiamphenicol-glycinate and thiamphenicol-glycinate-acetylcysteinate and other antimicrobials against respiratory pathogens.
2001
Patents

Patents

Sample Use Guides

Adult 500 mg 8 hrly. Childn 20-30 mg/kg/day. Gonorrhea 2.5 g/day for 1-2 days.
Route of Administration: Oral
THIAMPHENICOL AMINOACETATE inhibited M. catarrhalis with MIC90 0.5 ug/ml
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:07:02 UTC 2023
Edited
by admin
on Fri Dec 15 19:07:02 UTC 2023
Record UNII
W5H94CY6V6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
THIAMPHENICOL AMINOACETATE
WHO-DD  
Common Name English
THIOPHENICOL GLYCINATE
Common Name English
Thiamphenicol aminoacetate [WHO-DD]
Common Name English
THIAMPHENICOL GLYCINE ESTER
Common Name English
GLYCINE, (2R,3R)-2-((2,2-DICHLOROACETYL)AMINO)-3-HYDROXY-3-(4-(METHYLSULFONYL)PHENYL)PROPYL ESTER
Common Name English
THIAMPHENICOL GLYCINATE
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID7048326
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
MESH
C028813
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
PUBCHEM
115817
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
FDA UNII
W5H94CY6V6
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
CAS
2393-92-2
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
SMS_ID
100000084804
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
RXCUI
163416
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY RxNorm
DRUG CENTRAL
2625
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
EVMPD
SUB04801MIG
Created by admin on Fri Dec 15 19:07:03 UTC 2023 , Edited by admin on Fri Dec 15 19:07:03 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT